Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?
This summary was developed utilizing the full recorded presentation of this virtual forum, which is available on PsychU for all members free of charge. For full sourcing or polling results, please access the recording at https://psychu.org/future-psychopharmacology-new-treatment-innovation-still-alive/.
A dynamic presentation on the future of psychopharmacology was presented by Stephen M. Stahl, MD, PhD during a PsychU virtualforum on November 1, 2016. Dr. Stahl is a Professor of Psychiatry at University of California-San Diego, an Honorary Fellow at University of Cambridge, and Director …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.